Latest Esomeprazole Stories
--Practice Changing Study Calls on Doctors to Stop Prescribing Potent Heartburn Medications to Asthma Patients Without Frequent Symptoms of Gastric Reflux-- WASHINGTON, April 8 /PRNewswire-USNewswire/ -- For nearly 20 years, it was believed that severe asthma symptoms such as coughing, wheezing and breathlessness were triggered in part by acid reflux.
-Filing also includes age appropriate formulation of 2.5 mg and 5 mg strengths of NEXIUM for Delayed-Release Oral Suspension- WILMINGTON, Del., Dec. 19 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S.
According to a new study, stent patients who take the blood thinner Plavix combined with heartburn drugs may face a greater risk of heart attack.
POZEN Inc.'s (NASDAQ:POZN) PA32520 product candidate (enteric coated aspirin 325 mg with immediate release omeprazole 20 mg) may provide less upper gastrointestinal mucosal damage usually associated with higher doses of aspirin therapy, and may allow for treatment with higher doses of aspirin (up to 325 mg/daily) to maximize cardiovascular protection, according to new data presented today at the American Heart Association's (AHA) Scientific Sessions 2008 in New Orleans, Louisiana.
POZEN Inc. (NASDAQ:POZN), announced today that it will release third quarter 2008 results on October 29, 2008, before the market opens. The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time with a discussion by POZEN management of the earnings and business results.
POZEN Inc. (NASDAQ: POZN), today announced that the U.S.
POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will present at the UBS Life Sciences Conference on Tuesday, September 23, 2008 at 9:30 a.m. (ET) at the Grand Hyatt in New York. Dr.
POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka Pharm.D., the company's chairman, president and chief executive officer, will present at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 1:50 p.m. (ET) in New York City.
By Anonymous United States of America - The Food and Drug Administration (FDA) has approved esomeprazole magnesium (Nexium(R)) for short-term use in children 1-11 years of age for the treatment of gastroesophageal reflux disease (GERD).
POZEN Inc. (NASDAQ: POZN) announced today that William L. Hodges, the company's chief financial officer, will present at the 2008 BMO Capital Markets Focus on Healthcare Conference on Tuesday, August 5, 2008 at 10:45 a.m. (ET) at the Millennium Broadway Hotel in New York. Mr.
- Any of various tropical Old World birds of the family Indicatoridae, some species of which lead people or animals to the nests of wild honeybees. The birds eat the wax and larvae that remain after the nest has been destroyed for its honey.